Marine Fucosylated Chondroitin Sulfates
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: closed (1 March 2024) | Viewed by 72
Special Issue Editor
Interests: food science; marine bioactive substance; structure-function relationship
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Marine fucosylated chondroitin sulfates have become potential marine drugs or functional foods for arthrosis or several metabolic disorders, and are mainly isolated from fish cartilage, echinoderm, and skins. Notwithstanding the enormous efforts of academic researchers, numerous problems and difficulties also astrict the utilization of marine fucosylated chondroitin sulfates, including digestive absorption of the macromolecular polysaccharides, polysaccharide modifications, the novel structures and source of fucosylated chondroitin sulfates, structure–function relationships, etc. This Special Issue plans to give an overview of the most recent advances in the discovery of marine fucosylated chondroitin sulfates and their applications. This Special Issue is aimed at providing selected contributions on the aforementioned bottlenecks of marine fucosylated chondroitin sulfates’ development and application. Potential topics include, but are not limited to: novel structures of marine fucosylated chondroitin sulfates; chemical modifications on the structure of marine fucosylated chondroitin sulfates; new applications of marine fucosylated chondroitin sulfates; digestive absorption of marine fucosylated chondroitin sulfates in vivo; structure–function relationship of marine fucosylated chondroitin sulfates; future perspectives for marine fucosylated chondroitin sulfates
Dr. Shiwei Hu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine fucosylated chondroitin sulfates
- novel structure and source
- chemical modifications
- new applications
- digestive absorption
- structure–function relationship
- future perspectives
